Can Simvastatin Reduce the Need for Immunomodulatory Drugs to Treat Uveitis?
Objective: To assess the efficacy of simvastatin 80 mg/day versus placebo in patients with noninfectious nonanterior uveitis receiving prednisolone ≥ 10 mg/day. Design: Randomized, double-masked, controlled trial. Subjects: Adult patients with noninfectious nonanterior uveitis on oral prednisolone d...
Main Authors: | Ahmed Al-Janabi, PhD, FRCOphth, Lazha Sharief, PhD, FRCOphth, Noura Al Qassimi, MD, Yi-Hsing Chen, MD, PhD, Tao Ding, PhD, Gareth Ambler, PhD, Dimitris Ladas, MD, PhD, Sue Lightman, PhD, FRCOphth, Oren Tomkins-Netzer, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Ophthalmology Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666914523000659 |
Similar Items
-
A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis
by: Jonas J.W. Kuiper, PhD, et al.
Published: (2022-09-01) -
An Artificial Intelligence Approach to the Assessment of Abnormal Lid Position
by: Peter B. M. Thomas, PhD, FRCOphth, et al.
Published: (2020-10-01) -
Retinal and Choroidal Thickness in an Indigenous Population from Ghana
by: Moussa A. Zouache, PhD, et al.
Published: (2024-03-01) -
Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian Randomization
by: Amy V. Jones, PhD, et al.
Published: (2022-06-01) -
COVID-19 mRNA Vaccine–Associated Uveitis Leading to Diagnosis of Sarcoidosis: Case Report and Review of Literature
by: Toshihiko Matsuo MD, PhD, et al.
Published: (2022-03-01)